ad image

Dicerna

1 / 1
Novo Nordisk
Commercial Agreement

Dicerna™ Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection

Novo Nordisk

PR-M10-19-NI-050Nov 01, 2019
Eli Lilly, Dicerna to Collaborate on RNAi Drug Development
RNAi

Eli Lilly, Dicerna to Collaborate on RNAi Drug Development

Pharma's Almanac

PAO-M11-18-NI-006Nov 05, 2018
Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases
Strategic Partnership

Dicerna and Boehringer Ingelheim Ink Deal to Develop Treatments for Chronic Liver Diseases

Nice Insight

PAO-M11-17-NI-022Nov 14, 2017
1 / 1